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Statistics from the Northern Ireland Drug Misuse Database: 1 April 2013 – 31 March 2014 
This bulletin summarises information on people presenting to services with problem drug misuse and relates to the 
12-month period ending 31 March 2014. It is the thirteenth bulletin reporting on information collected through the 
Northern Ireland Drug Misuse Database (DMD), and collects detailed data on those presenting for treatment, 
including information on drugs misused and injecting behaviour. 
 
In Summary: 
 In Northern Ireland in 2013/14, a total of 2,574 clients presented 
to services for problem drug misuse and gave their consent for 
their details to be included in the DMD.  This was 9% lower than 
in 2012/13 (2,824 clients). 
 More than three-quarters of clients (77%) were male.  Male 
clients were younger than female clients. For males, 36% were 
aged 18-25 and 18% were aged over 40.  For females, 21% were 
aged 18-25 and 44% were aged over 40. 
 Approximately two-fifths of those presenting for treatment (39%) 
took just one drug, while a quarter (24%) took two drugs, 14% 
took three drugs and 23% took four or more drugs. 
 Over four-fifths of all clients (82%) used at least one hypnotic 
drug, with 60% of all clients using a hypnotic drug as their main 
drug. 
 Two-fifths of all clients (46%) used at least one stimulant drug, 
with 16% of all clients using a stimulant drug as their main drug.  
 Over one-quarter of all clients (29%) used at least one opioid 
analgesic drug, with 21% of all clients using an opioid analgesic 
drug as their main drug.  
 Considering all drugs used by clients, the most commonly 
reported drug was Cannabis (used by 62% of clients) followed by 
Benzodiazepines (used by 37% of clients) and Cocaine (used by 
30% of clients).   
 Cannabis was used by 39% of clients as the main drug of misuse 
in 2013/14, similar to 2012/13.  
 Almost one-third of those presenting for treatment (30%) had 
previously received treatment for their drug misuse.   
 The proportion of those who had ever injected stood at 10% in 
2013/14.   Injecting was notably higher in the Northern Trust 
(37% of clients) compared with all other Trusts (7-10%).    
 Between 2003/04 and 2013/14, use of Cocaine among clients 
rose from 17% to 30%, while use of Ecstasy (32% to 17%) and 
Heroin (15% to 10%) both fell. 
 
 
Contents 
Drug User Profile 
Use of Hypnotic Drugs 
Use of Stimulant Drugs 
Use of Opioid Analgesic Drugs 
Use of Solvents / Other Drugs 
 
Summary Statistics Map by Trust 
Notes to tables 
 
Tables 
Table 1: Drug User Profile by Trust 
Table 2: Treatment History by Trust 
Table 3: Injecting History by Trust 
Table 4: Main / Second / Third / Fourth 
/ Fifth Drugs and their use 
Table 5: Drug Combinations 
Table 6: Drug Profile 2013/14 
Table 7: Comparison 2011/12-2013/14 
 
 
 
 
 
Produced by: 
Public Health Information & 
Research Branch 
DHSSPS 
Castle Buildings,  
Belfast,  
BT4 3SQ 
Email: phirb@dhsspsni.gov.uk 
Telephone: 028 90522523 
 
      
     Page 
           2 
           4 
           5 
           6 
           7 
            
           8 
           8 
 
             
           9 
         12 
         12 
         13 
 
         14 
         15 
         16
Drug User Profile 
In 2013/14, a total of 2,574 clients presented to 
services for problem drug misuse for the first time or 
first time in six months and gave their consent for 
their details to be included in the DMD.  This was 9% 
lower than in 2012/13 (2,824 clients). 
Age of Clients by gender 
More than three-quarters of clients (77%) were male.  
Male clients were on average younger than female 
clients.  More than four-fifths of males (82%) were 
aged under 40 compared with almost three-fifths of 
females (56%).   
 
One quarter of all clients were in prison, with the 
majority of these being male (95%) and aged under 40 
(88%). 
 
Drugs Used 
Considering the range of drugs used by clients, 
Cannabis was the most commonly reported drug 
(used by 62% of clients) followed by Benzodiazepines 
(37% of clients). 
 
      Hypnotics      Stimulants      Opiates      Solvents      Other drugs  
 
Frequency of use 
Four-fifths of all users (80%) used at least one drug on 
a daily basis and a further 11% used at least one drug 
weekly.  The proportion of clients that had taken at 
least one drug in the last four weeks ranged from 75% 
in the Southern Trust to 89% in the Western Trust.  
This was true for two-fifths of clients in prison. 
  
Number of Drugs used 
Approximately two-fifths of those presenting for 
treatment (39%) took just one drug, while a quarter 
(24%) took two drugs, 14% took three drugs and 23% 
took four or more drugs. 
There was a marked difference between the number 
of drugs used by clients in prison in comparison with 
those who were not in prison.  Almost half of clients 
not in prison (48%) had one drug of misuse which 
compared with 14% of clients in prison.  The 
proportion of clients in prison using five drugs (28%) 
was four times that of clients not in prison (7%). 
 
 
 
Drug Combinations 
Drug combinations used varied between clients in 
prison and clients not in prison.  Three-fifths of non-
prison clients (60%) used just one drug type only 
compared with a fifth of prison clients (e.g. they took 
hypnotics or stimulants only although they may have 
taken more than one individual drug of that type).  
More than two-fifths of prison clients (44%) took a 
combination of two types of drug, while a third (32%) 
took a combination of three types of drug.   
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Over two-fifths of non-prison clients (43%) used 
hypnotic drugs only, with a fifth taking a combination 
of hypnotics and stimulants.  This compared with 28% 
of clients in prison that used a combination of 
hypnotics, stimulants and opioids and a further 28% 
that used a combination of hypnotics and stimulants. 
 
 
 
Use of Prescription drugs 
One-fifth of all clients (20%) took at least one 
prescribed drug, with females (42%) more likely to do 
so than males (13%).  The relatively high proportion of 
females that took prescribed drugs in the South 
Eastern Trust (63%) and the Belfast Trust (52%) was 
due to some extent to specialised Benzodiazepines 
projects being in place within those areas. 
 
Problem Use of Alcohol 
Problem alcohol use was reported by a quarter of 
clients (27%) ranging from 14% of those in the 
Northern Trust to 49% in the South Eastern Trust.  
Overall, 14% of clients reported alcohol as their main 
problem ranging from 8% in the Northern Trust and in 
prisons to 21% of clients in the Southern Trust. 
 
Proposed Treatment 
Clients could be offered one or more treatment 
services.  Two-thirds of clients (68%) were offered one 
treatment while a further 19% were offered two 
treatments. The most common treatment offered was 
counselling (68%) followed by Education / Information 
(43%) and detoxification (8%). 
 
 
Previous treatment 
Almost one-third of those presenting for treatment 
(30%) had previously received treatment for their 
drug misuse.  More than two-thirds of those 
previously treated had received counselling as part of 
their treatment (71%). 
 
 
Injecting History 
One-tenth of clients (10%) had ever injected their 
drugs.  Injecting was notably higher in the Northern 
Trust (37% of clients) than in all other Trusts.  Heroin 
use among clients in the Northern Trust (33%) was 
also much higher than all other Trusts (4%-8%) and 
double that of clients in prison (17%).   
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Of those who had ever injected, a third had shared 
injecting paraphernalia (30%) and had injected in the 
last four weeks (33%).  Three-fifths of those with an 
injecting history had been tested for HIV (60%), 
Hepatitis C (62%) and Hepatitis B (62%).  Over a 
quarter (27%) had been fully vaccinated against 
Hepatitis B, while a further 7% had been partly 
vaccinated. 
Attendance 
Almost half of all clients (45%) were required by 
others to attend for treatment, while a third (32%) 
chose to attend themselves and a fifth (22%) were 
persuaded by others.   
Referral 
Almost two-fifths of referrals came either from GPs 
(36%) or through the legal system (36%) while a tenth 
were self-referrals (10%). 
 
  
Attendance reason 
Clients could state one or more reasons for 
attendance for treatment.  The most common reason 
given was for psychological reasons (37%), followed 
by legal reasons (36%), family / relationships (32%), 
medical reasons (22%) with 16% citing other reasons.   
Dependent children 
A third of clients (34%) reported having dependent 
children ranging from 29% of those in prison and 
those in the Southern Trust to two-fifths of those in 
the Northern Trust (41%).  
Employment status 
Just over one-tenth of clients (12%) were in 
employment and 5% were students.  Almost half were 
unemployed (46%), a further 7% were receiving other 
benefits and 2% were retired.  A quarter of all clients 
were in prison or a young offender centre.   
Around a quarter of clients (26%) had worked in the 
last twelve months. 
Use of Hypnotic Drugs 
Use by gender 
Hypnotic drugs were the most commonly used type of 
drug by both males (83%) and females (77%).  
However, the use of individual hypnotic drugs varied 
greatly by gender.  Males were more likely to use 
Cannabis (71%) than females (32%) while females 
were more likely to use Benzodiazepines (43%) than 
males (36%). 
 
Over two-thirds of females using Benzodiazepines 
(70%) obtained them solely on prescription compared 
with a fifth of males (22%).  
Frequency of use 
The majority of those using Cannabis (77%), 
Benzodiazepines (71%) and other hypnotics (81%) did 
so on a daily basis.   
Route of Use 
The main route of use for Benzodiazepines, and other 
hypnotics was by taking them orally (both 100%) 
while the main route of use for Cannabis was smoking 
(89%). 
Age of first use  
The majority of clients using Cannabis (82%) had 
taken this drug under the age of 18. Almost three-
fifths of clients using other hypnotics (56%) first used 
these drugs aged 40 or over.   
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Age at presentation for treatment  
As per the age profile for first use, age at presentation 
for treatment for Cannabis was younger with more 
than half of clients aged 25 and under compared with 
a third of clients using Benzodiazepines and 8% of 
clients using other hypnotics. 
  
Use by Trust 
Hypnotic drugs were used by the majority of clients 
across all Trust areas ranging from 69% of those in the 
Southern Trust to 89% of those in prison.  However 
the level of use of individual hypnotic drugs varied 
widely across Trusts.  
Cannabis was the most commonly reported drug 
across all Trust areas with use ranging from 46% of 
clients in the South Eastern Trust area to 69% in the 
Western Trust area.  Cannabis was used by four-fifths 
of all clients in prison. 
Almost three-fifths of those in prison (56%) reported 
having used Benzodiazepines.  Use of other hypnotics 
(mainly Z-drugs such as Zopiclone which are thought 
to be less addictive and/or habit forming) was also 
highest in the Belfast (10%) and South Eastern Trusts 
(9%) with the vast majority of these having been 
prescribed. 
 
Comparison of use in 2013/14 with 2012/13  
Use of hypnotics among clients fell from 84% in 
2012/13 to 82% in 2013/14.  Use of Benzodiazepines 
fell from 44% to 37% with much of this decrease 
being attributed to a decrease in those receiving 
treatment within special Benzodiazepines projects in 
the Belfast and South Eastern Trust areas.  Use of 
Cannabis increased from 58% in 2012/13 to 62% in 
2013/14.  Use of Other Hypnotics (6%) was similar to 
the level of use in 2012/13 (7%). 
 
Use of Stimulant Drugs 
Use by gender 
Male clients (52%) were more likely to use stimulant 
drugs than female clients (27%).  This was true for 
each individual stimulant drug.  
 
Frequency of use 
Almost four-fifths of clients using Methedrone / 
Mephedrone (77%) did so at least on a weekly basis.   
This compared with 59% of clients using Cocaine, 52% 
of Ecstasy users and 59% of clients using other 
stimulant drugs.  Around two-fifths of clients using 
Ecstasy (43%), Cocaine (36%) and other Stimulants 
(38%) did so occasionally. 
Route of Use 
The main route of use for Cocaine (87%) and 
Methedrone / Mephedrone (72%) was by sniffing, 
while the main route of use for Ecstasy (98%) was 
orally.  
Age of first use  
With the exception of Ecstasy, the first use of 
stimulant drugs occurred for the highest percentage 
of clients between the age of 18 and 25 years.  Age of 
first use for Ecstasy users tended to be younger, with 
32% first using under sixteen years of age.  
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Age at presentation for treatment  
Three-fifths of clients using Methedrone / 
Mephedrone (62%) presented for treatment aged 
under 25 years.   This was higher than for Other 
Stimulants (52%), Ecstasy (48%) and Cocaine (45%). 
  
Use by Trust 
Use of any stimulant drug varied across the Trust 
areas ranging from a third of clients (30%) within the 
South Eastern Trust to over half of clients (54%) in the 
Western Trust.  Over two-thirds of clients in prison 
(68%) used stimulant drugs. 
Cocaine was used by over half of clients in prison 
(54%), while its use ranged from 12% of clients in the 
Northern Trust to 31% in the Southern Trust area.   
Over a quarter of clients in prison (26%) reported 
having used Ecstasy.  Outside prison, the highest use 
of Ecstasy was reported amongst clients in the 
Western Trust area (17%). 
Methedrone / Mephedrone was the second most 
commonly reported drug used in Western Trust area 
(34%).   
Other stimulants were used by a fifth of clients (21%) 
in prison.  Across Trusts, the use of other stimulants 
was highest in the Western Trust (25%) while it was 
used by 7% to 10% of clients in other Trust areas.   
  
Comparison of use in 2013/14 with 2012/13 
Use of any stimulant increased slightly from 42% of 
clients in 2012/13 to 46% in 2013/14.  Use of Cocaine 
increased from 27% to 30% of clients while use of 
Ecstasy decreased from 20% to 17% of clients.  Use of 
Methedrone / Mephedrone among clients remained 
relatively unchanged at 15%. 
 
Use of Opioid Analgesic Drugs 
Use by gender 
Male clients (11%) were almost twice as likely as 
female clients (6%) to use heroin.  Conversely the 
proportion of females using Codeine & Paracetamol 
(10%) was more than double that of males (4%). 
 
Frequency of use 
The majority of those using opioid analgesics used 
them on a daily basis. Four-fifths  of Codeine & 
Paracetamol users (80%) and around two-thirds of 
other opiate users (71%) and Heroin users (65%) took 
these drugs daily. 
 
Route of Use 
The main route of use for Codeine & Paracetamol 
(98%) and other opiates (92%) was orally.  The main 
route of use for Heroin was injecting (56%) followed 
by smoking (42%). 
 
Age of first use  
The highest proportion of clients had their first use of 
opioid analgesic drugs between the age of 18 and 25 
years, with over half of clients (51%) with problem 
Heroin use first using at this age.    
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 Age at presentation for treatment  
The highest proportion of clients using each opioid 
analgesic drug presented for treatment aged between 
26 and 39 years.  
 
 
Use by Trust 
Use of opioid analgesic drugs was highest in prisons 
(53%).  Use within the Northern Trust area (48%) was 
almost twice that in the South Eastern Trust (26%), 
with under a fifth of clients using opioid analgesics in 
the other Trust areas.   
Use of Heroin ranged from 4% in the Western Trust to 
a third of clients in the Northern Trust (33%). 
Almost two-fifths of clients in prisons (38%) used 
other opiates (mainly Tramadol).   
  
Comparison of use in 2013/14 with 2012/13 
There was no significant change in the overall use of 
opioid analgesic drugs between 2012/12 and 
2013/14.  Use of Heroin in the Northern Trust area 
increased from one-fifth (20%) to one-third (33%) of 
clients.  
 
Use of Solvents / Other Drugs 
Solvents  
Solvents were used by just 2% of clients overall in the 
region and was highest among clients in the Belfast 
Trust (3%).   Three-quarters of users (77%) first used 
them under the age of sixteen.  They were most likely 
to be used among clients as a fourth or fifth drug 
rather than as a main drug.  The route of use for 
solvents for the majority of clients was sniffing (89%). 
Other drugs  
The other drugs category includes hallucinogens, 
steroids and other drugs rarely reported by clients.  
Other drugs were used by 8% of clients.  Use across 
the Trusts varied from 4% of clients in the Northern 
Trust area to 11% in both the South Eastern and 
Western Trusts.  As with solvents, other drugs were 
most likely to be used as a fourth or fifth drug rather 
than as a main drug.  Over half of those who used 
these drugs had done so in the last four weeks. 
 
Comparison of use in 2013/14 with 2003/04 
The number of clients in treatment for drug misuse 
has risen from 1,409 in 2003/04 to 2,574 in 2013/14.  
This increase can mainly be attributed to increases in 
returns from the Belfast Trust and the Prisons.  
However returns from the Northern Trust area have 
decreased by two-fifths over this time. 
 
There was no difference in the use of Hypnotic drugs 
between 2003/04 and 2013/14, while use of 
Stimulants and Opioid Analgesics increased slightly. 
 
Between 2003/04 and 2013/14, Use of cocaine almost 
doubled from 17% of clients to 30%, while use of 
Ecstasy halved from 32% of clients to 17%.  Use of 
Heroin fell from 15% of clients to 10%.  Alongside this, 
the proportion of clients who had ever injected fell 
from 18% to 10%. 
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Notes to Tables 
1. A dashed line (-) represents a cell count of less than five.  This is in order to avoid issues involving personal 
disclosure, where it may be possible to identify an individual from the data provided.  All percentages are 
rounded to the nearest percentage point. 
2. A DMD form is completed for every client who presents at an Agency with a drug related problem for treatment.  
Clients must give their consent for data on the form to be used on the DMD (Consent was withheld for a total of 
136 DMD forms in 2013/14).  Only those problem drug users attending for the very first time or those who have 
not attended for treatment within the previous six months are recorded on the DMD.  This means that a small 
number of clients may be recorded twice on the DMD within one year (50 clients in 2013/14).   
3. Services available across Trusts vary and this may be reflected in the drugs misused.  For example, where special 
Benzodiazepines Projects exist, there will be greater proportions of clients presenting for treatment for problem 
Benzodiazepines use (i.e. in the Belfast and South Eastern Trust areas). 
4. Hypnotic drugs include Cannabis, Benzodiazepines and other Hypnotics.  Stimulant drugs include Cocaine, 
Ecstasy, Methedrone / Mephedrone and other Stimulants.  Opioid Analgesics include Heroin, Codeine & 
Paracetamol and other Opiates. 
 
 
Table 1:  Drug User Profile by Trust 
Trust Area Belfast Northern 
South 
Eastern Southern Western Prison Total 
Number of users within Trust 
Number of users in Trust (Headcount) 983 116 281 189 367 638 2,574 
% of all users on DMD 38.2 4.5 10.9 7.3 14.3 24.8 100.0 
Gender of users % 
Males (Headcount) 664 94 183 153 272 606 1,972 
Females (Headcount) 319 22 98 36 95 32 602 
% Male within Trust 67.5 81.0 65.1 81.0 74.1 95.0 76.6 
% Female within Trust 32.5 19.0 34.9 19.0 25.9 5.0 23.4 
Age of male users % 
Under 18 years 5.6 26.6 6.6 11.8 18.8 0.0 7.3 
18-25 years 31.5 14.9 26.2 33.3 37.5 46.7 35.9 
26-39 years 41.7 44.7 36.6 35.3 30.1 41.3 39.1 
40 years and over 21.2 13.8 30.6 19.6 13.6 12.0 17.7 
Age of female users % 
Under 18 years 3.1 13.6 5.1 5.6 11.6 0.0 5.1 
18-25 years 14.4 22.7 12.2 47.2 36.8 40.6 21.3 
26-39 years 29.8 40.9 25.5 27.8 29.5 43.8 30.1 
40 years and over 52.7 22.7 57.1 19.4 22.1 15.6 43.5 
Drug type for male users % 
Hypnotic drugs 81.5 75.5 83.1 69.9 82.0 89.8 83.1 
Stimulants 42.3 38.3 36.1 50.3 55.1 67.5 51.7 
Opioid Analgesics 17.3 40.4 26.2 15.0 15.8 52.1 29.6 
Solvents / Other Drugs 13.1 7.4 15.3 6.5 11.4 10.2 11.4 
Drug type for female users % 
Hypnotic drugs 80.6 45.5 84.7 63.9 67.4 78.1 76.7 
Stimulants 18.2 22.7 18.4 33.3 50.5 75.0 27.4 
Opioid Analgesics 19.7 81.8 24.5 36.1 27.4 59.4 27.1 
Solvents / Other Drugs 4.7 4.5 5.1 5.6 16.8 6.3 6.8 
Drug type for all users % 
Hypnotic drugs 81.2 69.8 83.6 68.8 78.2 89.2 81.6 
Stimulants 34.5 35.3 29.9 47.1 54.0 67.9 46.0 
Opioid Analgesics 18.1 48.3 25.6 19.0 18.8 52.5 29.0 
Solvents / Other Drugs 10.4 6.9 11.7 6.3 12.8 10.0 10.3 
Drugs used % 
Cannabis 50.8 61.2 45.9 64.6 69.5 79.6 61.5 
Benzodiazepines 35.9 17.2 43.1 10.6 23.2 56.4 37.3 
Other Hypnotics 10.4 0.0 8.9 - 3.3 1.7 5.9 
Cocaine 24.1 12.1 19.6 31.2 18.5 53.8 30.1 
Ecstasy 15.6 6.9 9.3 14.3 17.4 25.5 17.1 
Methedrone/Mephedrone 8.2 14.7 13.2 23.3 34.1 14.1 15.3 
Other Stimulants 7.9 9.5 10.3 7.4 24.8 21.5 14.0 
Heroin 6.4 32.8 4.6 8.5 4.4 16.6 9.8 
Codeine & Paracetamol 3.5 - 9.3 - 6.0 6.6 5.1 
Other Opiates 10.6 19.0 18.5 11.1 12.3 37.6 18.8 
Solvents 3.4 - - - 1.9 2.4 2.4 
Other Drugs 7.4 4.3 10.7 5.8 10.9 7.8 8.1 
Table 1:  Drug User Profile by Trust (Continued) 
Trust Area Belfast Northern 
South 
Eastern Southern Western Prison Total 
Number of drugs used % 
One drug 51.1 47.4 44.8 52.4 38.7 13.6 39.3 
Two drugs 25.8 31.9 26.0 23.3 21.3 18.7 23.5 
Three drugs 9.7 10.3 13.2 15.9 16.1 21.2 14.3 
Four drugs 6.7 7.8 7.1 6.3 11.2 18.2 10.3 
Five drugs 6.7 - 8.9 - 12.8 28.4 12.7 
Frequency of use % 
Daily 77.9 67.2 81.1 68.3 78.5 87.6 79.6 
Weekly 9.8 18.1 13.2 21.2 15.5 5.0 11.0 
Monthly 1.6 - - - 1.4 - 1.2 
Occasionally 10.4 13.8 4.6 9.0 4.6 6.9 8.1 
At least one drug used in last four 
weeks 
79.6 81.0 86.1 74.6 88.8 40.0 71.5 
Prescribed drugs % 
At least one drug prescribed 27.7 - 38.1 4.2 6.5 14.4 19.7 
Required / Persuaded / Own choice to attend (%) 
Wholly own choice 37.8 65.5 33.1 58.2 35.7 8.5 32.5 
Persuaded by others 19.6 25.0 29.5 30.7 53.4 2.5 22.3 
Required by others 42.5 9.5 37.4 11.1 10.9 89.0 45.2 
Reason for attendance (%) 
Legal 17.1 13.8 9.3 12.7 24.0 93.9 35.8 
Psychological 42.5 51.7 65.5 41.3 58.0 - 37.1 
Family/Relationships 33.0 57.8 53.7 47.1 53.7 - 32.3 
Medical e.g. detoxification 35.8 27.6 15.3 22.2 11.4 8.0 21.8 
Any other reason given  19.7 25.9 27.4 14.8 22.3 - 16.1 
Referral By (%) 
GP 41.3 33.6 68.3 58.7 48.2 0.0 35.9 
Prison / Young Offenders Centre / 
Probation / Drug Arrest Referral 
Scheme / Legal requirement 
19.3 19.8 1.8 5.8 14.4 99.1 35.5 
Self 17.9 12.1 8.2 5.8 7.1 - 9.8 
Psychiatric / Mental Health Service 4.3 6.9 9.3 10.6 8.2 - 4.9 
Social Services 2.7 8.6 3.2 4.8 7.1 0.0 3.1 
Other 14.4 19.0 9.3 14.3 15.0 - 10.7 
Legal Status (%) 
No Legal Status 72.9 67.2 85.4 78.8 66.2 0.0 55.4 
In Prison - - - - 0.0 100.0 25.1 
Community Supervision 14.9 9.5 3.9 3.2 9.3 0.0 8.1 
Trial Pending 4.0 6.0 6.8 9.5 13.1 0.0 5.1 
Other 8.0 16.4 4.6 7.9 13.1 0.0 6.8 
 
 
Table 1:  Drug User Profile by Trust (Continued) 
Trust Area Belfast Northern 
South 
Eastern Southern Western Prison Total 
Proposed Action (%) 
Counselling 61.3 44.8 39.5 67.7 70.6 93.1 67.9 
Education/Information 50.6 62.1 73.0 46.0 62.9 1.4 42.8 
Detoxification 14.5 5.2 7.1 7.4 6.5 1.1 8.3 
Advised screening for HIV/HEP B/C 6.4 25.9 - - 7.6 6.1 6.4 
Mentoring 7.9 5.2 8.9 4.2 11.4 - 6.3 
Prescribing Contract 10.8 4.3 - - 3.5 1.3 5.4 
Substitute Prescribing 2.4 27.6 4.6 6.9 2.5 3.1 4.3 
Family Support 2.2 6.0 4.3 5.8 7.1 0.0 3.0 
Rehabilitation 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
No intervention 0.0 0.0 0.0 0.0 0.0 0.0 0.0 
Other 5.5 4.3 15.3 3.7 2.5 2.7 5.2 
Living With (%) 
Prison / YOC - - - - 0.0 100.0 25.1 
Alone 29.7 19.8 28.1 25.9 29.2 0.0 21.4 
Parents / Parents & siblings 22.7 39.7 28.1 40.2 39.8 0.0 22.1 
Spouse / partner only 11.0 9.5 16.0 10.6 7.1 0.0 8.2 
Spouse / partner & dependent children 10.0 7.8 12.5 7.9 9.5 0.0 7.5 
Dependent children only 6.3 - 3.2 - 3.5 0.0 3.5 
Other 3.4 - 2.1 3.7 1.4 0.0 2.1 
Employment History (%) 
Worked in last 12 months 21.2 17.2 35.2 20.1 21.0 35.9 26.1 
Employment Status (%) 
Unemployed 65.8 51.7 41.6 73.0 63.2 0.0 46.4 
In prison / Young Offender Centre - - - - 0.0 100.0 25.1 
In Employment 17.0 8.6 24.6 12.7 11.7 0.0 12.2 
Receiving Other Benefits 5.9 16.4 23.5 - 6.3 0.0 6.6 
Student 4.1 15.5 4.6 10.1 13.4 0.0 5.4 
Retired/Receiving pension 5.4 0.0 2.5 - - 0.0 2.4 
On Govt training scheme 0.8 6.0 - - 3.8 0.0 1.3 
Other 0.6 - - 0.0 1.4 0.0 0.6 
Problem Alcohol Use % 
Problem alcohol use reported 24.0 13.8 48.8 33.9 37.9 15.7 26.9 
Alcohol main problem 14.9 7.8 14.9 21.2 17.2 8.3 13.7 
 
 
 
 
Table 2:  Treatment History by Trust 
Trust Area Belfast Northern 
South 
Eastern Southern Western Prison Total 
Drug Treatment History 
Ever Treated before (Headcount) 272 64 80 58 124 181 779 
Ever Treated before (%) 27.7 55.2 28.5 30.7 33.8 28.4 30.3 
Of those who have previously been treated - Previous Treatment (%)  
Counselling 71.7 39.1 72.5 63.8 91.9 69.6 71.2 
Detoxification 16.2 25.0 18.8 41.4 10.5 4.4 15.4 
Substitute Prescribing 9.6 53.1 15.0 8.6 9.7 18.2 15.7 
Rehabilitation 10.3 - 10.0 10.3 9.7 3.3 8.2 
Prescribing Contact 3.3 10.9 - - 4.8 - 3.9 
Of those who have previously been treated - Age first treated (%)  
Under 18 years 10.3 - - - 11.3 17.1 10.7 
18-21 years 22.8 18.8 18.8 22.4 21.0 32.6 24.0 
22-25 years 16.9 23.4 12.5 17.2 19.4 7.2 15.1 
26 years and over 40.4 39.1 55.0 39.7 41.9 16.0 36.3 
Unknown 8.8 12.5 8.8 13.8 5.6 26.5 13.1 
 
Table 3:  Injecting History by Trust 
       
 Trust Area Belfast Northern 
South 
Eastern Southern Western Prison Total 
Injecting history: 
Ever Injected (Headcount) 67 43 23 19 32 71 255 
Ever Injected (%) 6.8 37.1 8.2 10.1 8.7 11.1 9.9 
Of those who have injected - Sharing History (%) 
Ever Shared 29.9 39.5 26.1 26.3 28.1 26.8 29.8 
Of those who have injected - Use in last 4 weeks (%) 
Injected in the last 4 weeks 38.8 34.9 - 31.6 37.5 31.0 33.3 
Always used new equipment in last 4 
weeks 
76.9 80.0 75.0 100.0 75.0 72.7 77.6 
Rotated in the last 4 weeks 88.5 60.0 100.0 83.3 75.0 77.3 78.8 
Used Needle & Syringe Exchange in last 4 
weeks 
92.3 66.7 75.0 50.0 75.0 54.5 71.8 
Filtered in last 4 weeks 84.6 60.0 50.0 100.0 16.7 36.4 57.6 
Bleached in the last 4 weeks 42.3 20.0 50.0 83.3 - 27.3 32.9 
Shared equipment in the last 4 weeks 15.4 33.3 0.0 33.3 41.7 27.3 25.9 
Of those who have injected - Age first injected (%) 
Under 18 years 14.9 14.0 21.7 - - 18.3 14.5 
18-21 years 20.9 27.9 21.7 36.8 40.6 23.9 26.7 
22-25 years 28.4 16.3 30.4 - 18.8 21.1 22.4 
26 years and over 29.9 37.2 21.7 31.6 25.0 19.7 27.1 
Unknown - - - - - 16.9 9.4 
Of those who have injected - Testing for HIV / Hepatitis (%) 
HIV Tested 64.2 83.7 60.9 57.9 53.1 45.1 60.0 
Hepatitis C Tested 64.2 86.0 65.2 63.2 53.1 46.5 61.6 
Hepatitis B Tested 64.2 86.0 65.2 57.9 53.1 50.7 62.4 
Hepatitis B Fully Vaccinated 28.4 32.6 - 26.3 - 33.8 27.5 
Hepatitis B Part Vaccinated - - 21.7 - - 4.2 7.1 
Table 4:  Main / Second / Third / Fourth / Fifth Drugs and their use 
 Drug  Main Drug Second Drug  Third Drug  Fourth Drug  Fifth Drug  
Number of users 
Number of users on DMD 2,574 1,563 958 590 326 
% of users on DMD 100.0 60.7 37.2 22.9 12.7 
Gender of users 
Males (Headcount) 1,972 1,272 839 531 289 
Females (Headcount) 602 291 119 59 37 
% Male 76.6 81.4 87.6 90.0 88.7 
% Female 23.4 18.6 12.4 10.0 11.3 
% of all males registered 100.0 64.5 42.5 26.9 14.7 
% of all females registered 100.0 48.3 19.8 9.8 6.1 
Age of users at first face to face % 
Under 18 years 6.8 4.4 2.9 2.2 1.5 
18-25 years 32.4 37.4 44.4 50.0 56.4 
26-39 years 37.0 41.1 42.3 38.8 33.4 
40 years and over 23.8 17.2 10.4 9.0 8.6 
Age of first use % 
Under 16 years 31.9 25.2 28.2 31.4 28.8 
16-17 years 16.3 21.4 25.1 26.1 27.6 
18-25 years 26.5 32.6 33.2 33.1 33.7 
26-39 years 14.5 13.0 10.8 6.6 7.4 
40 years & over 9.8 6.2 1.8 1.7 1.8 
Not known 1.0 1.5 1.0 1.2 - 
Drug Type for Male users % 
Hypnotic drugs 58.6 41.9 34.2 30.3 22.1 
Stimulants 17.2 42.3 50.7 52.5 50.5 
Opioid Analgesics 21.3 11.3 8.9 8.1 16.6 
Solvents / Other Drugs 2.8 4.5 6.2 9.0 10.7 
Drug Type for Female users % 
Hypnotic drugs 63.3 47.8 29.4 25.4 27.0 
Stimulants 13.1 32.3 47.1 49.2 54.1 
Opioid Analgesics 20.6 15.1 18.5 16.9 - 
Solvents / Other Drugs 3.0 4.8 5.0 8.5 - 
Drug % 
Cannabis 38.7 17.0 17.6 18.1 15.3 
Benzodiazepines 17.1 23.2 15.3 11.2 7.4 
Other Hypnotics 3.9 2.8 0.6 - 0.0 
Cocaine 8.2 17.7 18.4 14.1 8.6 
Ecstasy 0.8 8.4 13.4 17.6 20.6 
Methedrone/Mephedrone 4.1 7.7 8.8 8.0 11.7 
Other Stimulants 3.1 6.6 9.7 12.5 10.1 
Heroin 7.9 1.5 1.1 1.5 1.8 
Codeine & Paracetamol 2.7 2.0 2.0 1.4 1.8 
Other Opiates 10.5 8.5 7.0 6.1 12.0 
Solvents 0.6 1.0 1.0 2.4 3.1 
Other Drugs 2.3 3.6 5.0 6.6 7.7 
Frequency of use % 
Daily 72.6 49.3 38.4 34.1 28.2 
Weekly 13.2 25.5 29.3 26.9 31.0 
Monthly 1.6 3.0 3.2 3.1 3.4 
Occasionally 12.4 22.2 29.0 35.9 37.4 
Used in last four weeks 66.2 48.1 33.5 33.5 19.0 
Table 4:  Main / Second / Third / Fourth / Fifth Drugs and their use (Continued) 
Drug Number Main Drug Second Drug  Third Drug  Fourth Drug  Fifth Drug  
Prescribed drugs % 
Only prescribed 16.4 12.0 4.8 2.4 1.5 
Prescribed & others 4.0 4.5 3.3 2.0 2.5 
Route of use % 
Oral 43.7 53.7 47.6 49.2 53.4 
Smoke 39.1 18.6 20.0 20.8 19.9 
Sniff 11.8 25.8 30.2 28.1 25.5 
Inject 5.2 1.7 1.8 1.7 - 
Other - - - 0.0 0.0 
Treated before % 
Treated before 30.3 35.1 37.8 41.2 47.5 
Table 5:  Drug Combinations 
Number of Drugs Taken  One  Two  Three  Four  Five  
Number of users 
Number of users on DMD 1,011 605 368 264 326 
% of users on DMD 39.3 23.5 14.3 10.3 12.7 
Gender of users 
Males (Headcount) 700 433 308 242 289 
Females (Headcount) 311 172 60 22 37 
% Male 69.2 71.6 83.7 91.7 88.7 
% Female 30.8 28.4 16.3 8.3 11.3 
% of all males registered 35.5 22.0 15.6 12.3 14.7 
% of all females registered 51.7 28.6 10.0 3.7 6.1 
Age of users at first face to face % 
Under 18 years 10.5 6.6 4.1 3.0 1.5 
18-25 years 24.8 26.3 35.3 42.0 56.4 
26-39 years 30.8 39.2 47.8 45.5 33.4 
40 years and over 33.9 27.9 12.8 9.5 8.6 
Age of first use % 
Under 16 years 31.1 35.2 53.5 60.2 72.4 
16-17 years 14.1 17.2 20.4 21.2 17.5 
18-25 years 21.6 22.6 17.7 15.5 8.3 
26-39 years 16.2 12.7 6.5 1.9 1.8 
40 years & over 16.1 10.7 - - 0.0 
Not known 0.9 1.5 - - 0.0 
Drug Combinations 
Hypnotics only 72.3 26.3 1.4 0.4 0.0 
Stimulants only 10.6 8.4 4.6 1.9 0.3 
Opioids only 13.8 4.6 2.7 0.0 0.0 
Solvents / Other Drugs only 3.3 0.8 0.0 0.0 0.0 
Hypnotics & Stimulants   33.7 44.3 38.3 29.4 
Hypnotics & Opioids   17.0 20.7 8.0 3.1 
Other 2 drug type combination   9.1 8.2 4.2 1.8 
Hypnotics, Stimulants & Opioids     10.6 28.8 38.7 
Hypnotics, Stimulants & 
Solvents/Other Drugs     6.5 12.1 13.5 
Other 3 drug type combination     1.1 3.0 3.4 
4 / 5 drug type combination       3.4 9.8 
Treated before % 
Treated before 22.7 30.9 32.3 33.3 47.5 
Table 6:  Drug Profile 2012/13 
Drug Type Hypnotics Stimulants Opioid Analgesics 
Solvents 
Other 
Drugs Drug   Cannabis Benzos 
Other 
Hypnotics Cocaine Ecstasy 
Methedrone/ 
Mephedrone 
Other 
Stimulants Heroin 
Codeine & 
Paracetamol 
Other 
Opiates 
Number of Users 
Number of users on DMD 1,584 959 151 776 441 394 360 252 132 484 62 209 
% of total registered on DMD 61.5 37.3 5.9 30.1 17.1 15.3 14.0 9.8 5.1 18.8 2.4 8.1 
Gender Profile of Users  - % of all registered on DMD of each gender using 
Males (Headcount) 1,392 703 57 690 385 323 301 214 71 391 58 172 
Females (Headcount) 192 256 94 86 56 71 59 38 61 93 - 37 
% of all males using... 70.6 35.6 2.9 35.0 19.5 16.4 15.3 10.9 3.6 19.8 2.9 8.7 
% of all females using... 31.9 42.5 15.6 14.3 9.3 11.8 9.8 6.3 10.1 15.4 - 6.1 
Age of users at first face to face % 
Under 18 years 9.9 1.4 - 1.5 2.9 6.1 10.6 0.0 - - 9.7 6.7 
18-25 years 44.3 34.1 6.0 43.4 45.4 55.6 41.4 15.1 25.8 34.9 29.0 33.5 
26-39 years 34.8 33.6 16.6 45.7 41.7 30.2 36.9 65.9 40.9 47.9 56.5 36.4 
40 years and over 11.0 31.0 75.5 9.3 10.0 8.1 11.1 19.0 31.8 16.3 - 23.4 
Age at first use % 
Under 16 years 62.2 18.8 3.3 16.4 31.7 13.5 21.7 5.6 6.1 14.5 77.4 18.7 
16-17 years 20.1 18.1 4.0 27.2 31.2 24.6 30.8 14.7 9.1 15.5 11.3 15.8 
18-25 years 12.7 32.1 11.9 43.9 31.5 37.3 33.9 51.2 42.4 40.9 9.7 34.9 
26-39 years 3.3 13.9 24.5 10.5 4.2 18.3 9.4 25.4 31.8 23.3 0.0 20.1 
40 years & over 0.9 16.0 55.6 1.0 - 4.8 2.8 - 10.6 4.5 0.0 7.7 
Not known 0.8 1.1 - 1.0 - 1.5 1.4 2.4 0.0 1.2 - 2.9 
Frequency of use % 
Daily 77.0 71.0 80.8 21.2 6.6 27.9 30.8 65.5 80.3 71.3 27.4 48.8 
Weekly 10.2 12.4 6.0 37.3 45.8 49.5 28.3 13.1 6.1 11.8 37.1 21.1 
Monthly 1.6 1.1 0.0 5.3 4.7 3.3 3.1 2.8 - 1.7 - 2.4 
Occasionally 11.0 15.4 13.2 36.2 43.0 19.3 37.8 17.9 12.9 15.3 33.9 27.8 
Used in last four weeks 58.8 63.0 90.1 25.8 13.4 45.2 34.7 44.4 72.7 56.8 16.1 53.1 
Route of Use % 
Oral 9.8 99.7 100.0 7.5 97.9 19.3 43.3 - 97.7 92.1 8.1 82.3 
Smoke 89.3 - 0.0 4.4 - 3.6 18.1 42.1 - 1.0 - 5.3 
Sniff 0.9 0.0 0.0 86.8 1.9 72.3 36.1 - - 5.2 88.7 6.7 
Inject 0.0 0.0 0.0 1.1 0.0 4.6 2.2 55.6 0.0 - 0.0 4.8 
Other 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 - 0.0 - 
Table 7:  Comparison 2011/12, 2012/13 and 2013/14 
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Number of users within Trust 
Number of users in Trust 
(Headcount) 
1,239 129 430 243 318 640 2,999 1,033 152 446 112 378 703 2,824 983 116 281 189 367 638 2,574 
% of all users on DMD 41.3 4.3 14.3 8.1 10.6 21.3 100.0 36.6 5.4 15.8 4.0 13.4 24.9 100.0 38.2 4.5 10.9 7.3 14.3 24.8 100.0 
Gender of users % 
Males (Headcount) 832 99 250 209 235 627 2,252 731 126 276 97 275 679 2,184 664 94 183 153 272 606 1,972 
Females (Headcount) 407 30 180 34 83 13 747 302 26 170 15 103 24 640 319 22 98 36 95 32 602 
% Male within Trust 67.2 76.7 58.1 86.0 73.9 98.0 75.1 70.8 82.9 61.9 86.6 72.8 96.6 77.3 67.5 81.0 65.1 81.0 74.1 95.0 76.6 
% Female within Trust 32.8 23.3 41.9 14.0 26.1 2.0 24.9 29.2 17.1 38.1 13.4 27.2 3.4 22.7 32.5 19.0 34.9 19.0 25.9 5.0 23.4 
Age of male users % 
Under 18 years 6.4 26.3 10.8 18.7 12.3 1.1 8.0 6.7 27.8 9.8 34.0 10.5 0.0 7.9 5.6 26.6 6.6 11.8 18.8 0.0 7.3 
18-25 years 33.5 25.3 24.8 26.3 40.4 48.6 36.5 31.3 24.6 22.5 23.7 37.5 53.6 37.2 31.5 14.9 26.2 33.3 37.5 46.7 35.9 
26-39 years 37.9 39.4 37.6 38.8 31.1 42.4 38.5 36.8 40.5 35.9 30.9 37.5 36.5 36.6 41.7 44.7 36.6 35.3 30.1 41.3 39.1 
40 years and over 22.2 9.1 26.8 16.3 16.2 7.8 17.0 25.2 7.1 31.9 11.3 14.5 9.9 18.3 21.2 13.8 30.6 19.6 13.6 12.0 17.7 
Age of female users % 
Under 18 years 1.2 30.0 2.8 20.6 12.0 0.0 4.8 1.3 26.9 2.4 20.0 6.8 0.0 3.9 3.1 13.6 5.1 5.6 11.6 0.0 5.1 
18-25 years 14.0 30.0 13.3 23.5 30.1 61.5 17.5 12.3 11.5 11.2 53.3 35.0 41.7 17.7 14.4 22.7 12.2 47.2 36.8 40.6 21.3 
26-39 years 25.1 23.3 18.3 29.4 44.6 30.8 25.8 26.8 42.3 17.1 13.3 37.9 54.2 27.3 29.8 40.9 25.5 27.8 29.5 43.8 30.1 
40 years and over 59.7 16.7 65.6 26.5 13.3 7.7 51.8 59.6 19.2 69.4 13.3 20.4 4.2 51.1 52.7 22.7 57.1 19.4 22.1 15.6 43.5 
Drug type for male users % 
Hypnotic drugs 85.2 75.8 88.0 77.0 87.7 83.6 84.1 84.8 79.4 87.0 78.4 81.8 87.6 85.0 81.5 75.5 83.1 69.9 82.0 89.8 83.1 
Stimulants 35.9 31.3 28.4 59.8 57.0 54.7 44.5 40.4 27.8 27.9 45.4 53.5 63.8 47.2 42.3 38.3 36.1 50.3 55.1 67.5 51.7 
Opioid Analgesics 15.4 38.4 28.8 15.3 12.3 27.3 20.9 16.7 42.1 22.8 20.6 18.9 45.5 28.3 17.3 40.4 26.2 15.0 15.8 52.1 29.6 
Solvents / Other Drugs 8.9 5.1 6.8 4.3 11.9 18.2 11.0 10.1 4.8 8.3 - 11.6 10.2 9.4 13.1 7.4 15.3 6.5 11.4 10.2 11.4 
Drug type for female users % 
Hypnotic drugs 84.5 53.3 88.9 47.1 67.5 84.6 80.7 87.1 53.8 90.0 53.3 59.2 83.3 81.1 80.6 45.5 84.7 63.9 67.4 78.1 76.7 
Stimulants 15.2 46.7 9.4 35.3 54.2 53.8 21.0 12.3 38.5 8.8 60.0 50.5 79.2 22.2 18.2 22.7 18.4 33.3 50.5 75.0 27.4 
Opioid Analgesics 15.7 43.3 36.7 41.2 36.1 53.8 26.0 12.3 46.2 21.2 26.7 31.1 91.7 22.3 19.7 81.8 24.5 36.1 27.4 59.4 27.1 
Solvents / Other Drugs 4.2 6.7 4.4 5.9 12.0 23.1 5.6 6.0 7.7 4.7 0.0 14.6 0.0 6.7 4.7 4.5 5.1 5.6 16.8 6.3 6.8 
 
Table 7:  Comparison 2011/12, 2012/13 and 2013/14 (Continued) 
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Drugs used % 
Cannabis 46.4 58.9 40.2 67.1 78.9 76.6 57.6 48.8 66.4 34.1 69.6 70.1 75.2 57.7 50.8 61.2 45.9 64.6 69.5 79.6 61.5 
Benzodiazepines 45.1 31.8 57.7 12.3 13.5 26.3 36.3 46.4 21.1 60.3 8.9 16.9 56.0 44.2 35.9 17.2 43.1 10.6 23.2 56.4 37.3 
Other Hypnotics 9.2 0.0 11.2 - 0.0 8.8 7.4 7.6 - 8.7 - 1.6 0.9 4.7 10.4 0.0 8.9 - 3.3 1.7 5.9 
Cocaine 18.6 14.0 12.3 30.0 30.8 38.4 23.9 20.6 13.2 11.0 22.3 25.4 49.6 26.6 24.1 12.1 19.6 31.2 18.5 53.8 30.1 
Ecstasy 12.7 10.9 6.0 22.2 28.3 13.0 14.1 18.5 13.2 7.6 16.1 25.9 30.6 20.4 15.6 6.9 9.3 14.3 17.4 25.5 17.1 
Methedrone / 
Mephedrone 11.4 20.2 10.5 35.8 36.2 6.3 15.1 8.4 15.8 9.9 35.7 34.1 16.4 15.5 8.2 14.7 13.2 23.3 34.1 14.1 15.3 
Other Stimulants 4.4 7.8 6.0 9.9 13.8 18.1 9.1 5.0 11.2 4.0 - 14.3 18.3 9.7 7.9 9.5 10.3 7.4 24.8 21.5 14.0 
Heroin 6.2 24.0 3.5 7.8 3.8 11.3 7.5 6.5 20.4 2.9 13.4 6.1 14.1 8.8 6.4 32.8 4.6 8.5 4.4 16.6 9.8 
Codeine & Paracetamol 3.3 - 17.4 3.3 8.5 2.3 5.6 3.1 3.9 6.7 - 5.8 6.3 4.8 3.5 - 9.3 - 6.0 6.6 5.1 
Other Opiates 8.6 22.5 17.7 10.3 12.6 18.3 13.1 9.0 23.0 16.1 9.8 14.3 35.0 18.1 10.6 19.0 18.5 11.1 12.3 37.6 18.8 
Solvents 2.9 - 1.6 - 2.2 7.2 3.4 2.9 - - 0.0 1.6 4.6 2.5 3.4 - - - 1.9 2.4 2.4 
Other Drugs 4.9 3.9 4.4 2.9 10.1 13.6 7.0 6.5 4.6 6.7 - 10.8 6.1 6.7 7.4 4.3 10.7 5.8 10.9 7.8 8.1 
Number of drugs used % 
One drug 51.6 44.2 39.1 43.2 37.4 30.0 42.7 48.0 44.1 49.1 50.9 39.2 17.8 39.4 51.1 47.4 44.8 52.4 38.7 13.6 39.3 
Two drugs 27.4 29.5 33.7 23.5 20.4 28.0 27.5 27.6 27.6 30.5 23.2 18.8 19.1 24.6 25.8 31.9 26.0 23.3 21.3 18.7 23.5 
Three drugs 10.0 10.1 14.7 21.0 14.5 20.9 14.4 12.3 16.4 10.5 17.0 17.2 18.1 14.5 9.7 10.3 13.2 15.9 16.1 21.2 14.3 
Four drugs 6.3 10.1 7.7 7.8 14.5 10.2 8.5 7.0 6.6 5.4 6.3 14.6 18.5 10.6 6.7 7.8 7.1 6.3 11.2 18.2 10.3 
Five drugs 4.7 6.2 4.9 4.5 13.2 10.9 7.0 5.1 5.3 4.5 - 10.3 26.6 11.0 6.7 - 8.9 - 12.8 28.4 12.7 
Frequency of use % 
Daily 77.2 80.6 84.7 65.8 69.5 66.4 74.4 77.1 69.1 85.2 68.8 71.2 84.8 78.7 77.9 67.2 81.1 68.3 78.5 87.6 79.6 
Weekly 9.3 13.2 9.5 25.5 19.2 9.5 11.9 10.8 23.7 10.3 23.2 17.5 6.8 11.8 9.8 18.1 13.2 21.2 15.5 5.0 11.0 
Monthly 1.0 - - 2.9 2.2 0.8 1.2 0.7 - 1.3 - - 0.9 1.0 1.6 - - - 1.4 - 1.2 
Occasionally 12.3 4.7 5.1 5.8 8.8 22.0 12.1 11.3 5.3 3.1 6.3 10.3 7.5 8.4 10.4 13.8 4.6 9.0 4.6 6.9 8.1 
At least one drug used in 
last four weeks 
83.4 90.7 89.8 84.0 85.8 41.6 76.0 82.8 80.3 89.9 85.7 85.2 39.7 73.5 79.6 81.0 86.1 74.6 88.8 40.0 71.5 
Injecting history % 
Ever Injected  6.0 24.0 4.9 5.8 8.8 7.8 7.3 7.8 21.7 5.8 10.7 8.5 9.8 9.0 6.8 37.1 8.2 10.1 8.7 11.1 9.9 
Table 8:  Comparison 2003/04 and 2013/14 
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Number of users within Trust 
Number of users in Trust (HC) 375 199 255 136 337 107 1,409 983 116 281 189 367 638 2,574 
% of all users on DMD 26.6 14.1 18.1 9.7 23.9 7.6 100.0 38.2 4.5 10.9 7.3 14.3 24.8 100.0 
Gender of users % 
Males (Headcount) 290 158 156 103 251 106 1,064 664 94 183 153 272 606 1,972 
Females (Headcount) 85 41 99 33 86 - 345 319 22 98 36 95 32 602 
% Male within Trust 77.3 79.4 61.2 75.7 74.5 99.1 75.5 67.5 81.0 65.1 81.0 74.1 95.0 76.6 
% Female within Trust 22.7 20.6 38.8 24.3 25.5 - 24.5 32.5 19.0 34.9 19.0 25.9 5.0 23.4 
Age of all users % 
Under 18 years 20.0 22.6 45.5 15.4 16.3 5.6 22.6 4.8 24.1 6.0 10.6 16.9 0.0 6.8 
18-25 years 41.1 37.7 17.6 29.4 39.5 68.2 36.9 25.9 16.4 21.4 36.0 37.3 46.4 32.4 
26-39 years 31.2 33.2 28.6 41.9 33.2 19.6 31.7 37.8 44.0 32.7 33.9 30.0 41.4 37.0 
40 years and over 7.7 6.5 8.2 13.2 11.0 6.5 8.9 31.4 15.5 39.9 19.6 15.8 12.2 23.8 
Drug type for all users % 
Hypnotic drugs 76.5 83.9 82.7 85.3 84.3 80.4 81.7 81.2 69.8 83.6 68.8 78.2 89.2 81.6 
Stimulants 45.6 39.2 29.0 44.1 44.2 52.3 41.7 34.5 35.3 29.9 47.1 54.0 67.9 46.0 
Opioid Analgesics 25.9 46.7 20.0 31.6 19.3 14.0 25.8 18.1 48.3 25.6 19.0 18.8 52.5 29.0 
Solvents / Other Drugs 15.5 6.0 9.8 8.8 13.1 15.9 11.9 10.4 6.9 11.7 6.3 12.8 10.0 10.3 
Drugs used % 
Cannabis 67.7 63.3 69.0 73.5 73.0 72.9 69.6 50.8 61.2 45.9 64.6 69.5 79.6 61.5 
Benzodiazepines 19.2 37.7 18.4 16.9 16.0 29.9 21.5 35.9 17.2 43.1 10.6 23.2 56.4 37.3 
Other Hypnotics 1.3 0.0 2.0 - 2.4 0.0 1.4 10.4 0.0 8.9 0.5 3.3 1.7 5.9 
Cocaine 18.1 10.6 11.4 18.4 17.8 28.0 16.5 24.1 12.1 19.6 31.2 18.5 53.8 30.1 
Ecstasy 36.5 33.2 21.6 37.5 31.8 33.6 32.1 15.6 6.9 9.3 14.3 17.4 25.5 17.1 
Methedrone/Mephedrone               8.2 14.7 13.2 23.3 34.1 14.1 15.3 
Other Stimulants 13.6 17.1 14.5 10.3 26.1 15.0 17.0 7.9 9.5 10.3 7.4 24.8 21.5 14.0 
Heroin 17.1 40.2 9.0 14.7 5.3 11.2 15.4 6.4 32.8 4.6 8.5 4.4 16.6 9.8 
Codeine & Paracetamol               3.5 3.4 9.3 2.1 6.0 6.6 5.1 
Other Opiates 14.7 27.6 16.1 22.1 14.8 - 16.7 10.6 19.0 18.5 11.1 12.3 37.6 18.8 
Solvents 9.6 3.5 6.7 - 6.5 6.5 6.6 3.4 2.6 1.1 0.5 1.9 2.4 2.4 
Other Drugs 6.1 3.0 3.9 6.6 6.8 10.3 5.8 7.4 4.3 10.7 5.8 10.9 7.8 8.1 
Number of drugs used % 
One drug 41.9 39.7 57.6 38.2 48.7 29.0 44.7 51.1 47.4 44.8 52.4 38.7 13.6 39.3 
Two drugs 23.5 13.6 22.4 27.9 20.2 36.4 22.5 25.8 31.9 26.0 23.3 21.3 18.7 23.5 
Three drugs 18.9 19.1 8.6 16.9 16.3 21.5 16.5 9.7 10.3 13.2 15.9 16.1 21.2 14.3 
Four drugs 10.9 13.6 7.1 10.3 7.4 8.4 9.5 6.7 7.8 7.1 6.3 11.2 18.2 10.3 
Five drugs 4.8 14.1 4.3 6.6 7.4 4.7 6.8 6.7 2.6 8.9 2.1 12.8 28.4 12.7 
Frequency of use % 
Daily 75.7 83.4 59.2 71.3 81.6 79.4 75.1 77.9 67.2 81.1 68.3 78.5 87.6 79.6 
Weekly 16.8 12.1 21.6 21.3 13.1 11.2 16.1 9.8 18.1 13.2 21.2 15.5 5.0 11.0 
Monthly - 0.0 5.1 - 2.4 - 1.8 1.6 0.9 1.1 1.6 1.4 0.5 1.2 
Occasionally 5.6 4.0 13.7 6.6 2.7 4.7 6.2 10.4 13.8 4.6 9.0 4.6 6.9 8.1 
At least one drug used in last 
four weeks 90.1 88.9 89.8 89.7 89.9 68.2 88.1 79.6 81.0 86.1 74.6 88.8 40.0 71.5 
Injecting history % 
Ever Injected  18.4 40.7 11.8 14.7 13.1 14.0 18.4 6.8 37.1 8.2 10.1 8.7 11.1 9.9 
In 2003/04, Methedrone/Mephedrone and Codeine & Paracetamol were not named drugs on the DMD, therefore they are not reported separately. 
